ADVERSE PREGNANCY OUTCOMES IN SICKLE CELL TRAIT: A PROSPECTIVE COHORT STUDY EVALUATING CLINICAL AND HAEMATOLOGICAL PARAMETERS IN POSTPARTUM MOTHERS AND NEW-BORNS. Sickle cell trait pregnancy and outcomes
Main Article Content
Keywords
Sickle cell trait, pregnancy, pregnancy outcome
Abstract
Abstract – Sickle cell trait (SCT) is a condition caused by the inheritance of a single allele of the abnormal haemoglobin beta gene, HbS. Carriers of SCT are generally asymptomatic, and they do not manifest the haematological and clinical abnormalities of sickle cell anaemia (SCA). However, there is evidence that they display some of the symptoms in stressful situations. Pregnancy is a stressful physiological event, and it is not clear if SCT adversely affects pregnancy outcomes, particularly those from the developing countries, who regularly suffer from nutritional insufficiency.
Objective – This study aims to investigate pregnancy outcomes in Sudanese women with SCT.
Subjects and methods – Pregnant women with (HbAS, n=34) and without (HbAA, n=60) SCT were recruited during their first trimester by El Obeid Hospital, Kordofan, Western Sudan. Ethical approval from the Faculty of Medicine, University of Khartoum, and informed consent from the participants were obtained. Detailed anthropometric, haematological, clinical, obstetric and birth outcome data were documented. Blood samples were collected at enrolment and delivery.
Results – At enrolment, the first trimester, the SCT group did not manifest SCA symptoms, and there was no difference in any of the haematological parameters between the SCT and control groups. At delivery, the women with SCT compared with the control group had lower levels of haemoglobin (Hb, p=0.000), packed cell volume (PCV, p=0.000), mean corpuscular haemoglobin (MCH, p=0.002) and neutrophil counts (p=0.045) and higher mean corpuscular volume (MCV, p=0.000) and platelet counts (p=0.000). Similarly, at delivery, the babies of SCT women had lower birth weight (p=0.000), lower Hb (p=0.045), PCV (p=0.000), MCH (p=0.000) and higher neutrophil (p=0.004) and platelet counts (p=0.000) than the babies of the healthy control group. Additionally, there were more miscarriages, stillbirths and admissions to the Special Care Baby Unit (SCBU) in the SCT group.
Conclusions – The study revealed that SCT is associated with adverse pregnancy outcomes, including maternal and neonatal anaemia, low birth weight and increased risk of still birth, miscarriage and admission to SCBU. Therefore, pregnant women with SCT should be regarded as a high-risk group, and given pre-conceptual advice and multidisciplinary antenatal and postnatal care.
Downloads
Abstract 646
PDF Downloads 833
HTML Downloads 323
References
1. Ware RE, de Montalembert M, Tshilolo L Abboud MR, sickle cell disease. Lancet. 2017 Jul 15;390(10091):311-323. doi: 10.1016/S0140-6736(17)30193-9. Epub 2017 Feb 1
2. Archibald RG. A case of sickle cell anaemia in Sudan. Trans R Soc Trop Med Hyg 1926; 19: 389–39. https://doi.org/10.1016/S0035-9203(26)90485-9
3. Adam MA, Adam NK, Mohamed BA. Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan. BMC Research Notes 2019; 12. Available at: https://bmcresnotes. biomedcentral. com/articles /10.1186/s13104-019-4682-5. Accessed March 5, 2020.
4. Daak AA, Elsamani E, Ali EH, et al. Sickle cell disease in western Sudan: genetic epidemiology and predictors of knowledge attitude and practices. Trop Med Int Health 2016; 21:642–653. doi: 10.1111/tmi.12689. Epub 2016 Mar 29
5. Sabahelzain MM, Hamamy H. The ethnic distribution of sickle cell disease in Sudan. Pan Afr Med J. 2014 May 3;18:13. doi: 10.11604/pamj.2014.18.13.3280. eCollection 2014
6. Saha N. · Hamad R.E. Mohamed S.c Inbreeding Effects on Reproductive Outcome in a Sudanese Population. Hum Hered 1990;40:208–212. https://doi.org/10.1159/000153932
7. El-Hazmi M, Al-Hazmi, MA, Warsy AS. Sickle cell disease in Middle East Arab countries Indian J Med Res. 2011 Nov; 134(5): 597–610. doi: 10.4103/0971-5916.90984. PMCID: PMC3249957.
8. Oakley LL, Mitchell S, von Rege I, Hadebe R, Howard J, Robinson SE, Oteng-Ntim E. Perinatal outcomes in women with sickle cell disease: a matched cohort study from London, UK. Br J Haematol. 2021 Dec 8. doi: 10.1111/bjh.17983. Online ahead of print. PMID: 34881428
9. Yeral M , Boğa C. Is Sickle Cell Trait Really Innocent?. Turk J Haematol. 2021 Jun 1;38(2):159-160. doi: 10.4274/tjh.galenos.2020.2020.0344. Epub 2020 Oct 15.
10. Abdulsalam, A. A., Bashour, H. N., Monem, F. S, Hamadeh FM, Pregnancy outcome among Palestinian refugee women with sickle cell trait in Damascus, Syria. Saudi Med J. 2003 Sep;24(9):986-90. PMID: 12973484
11. Adam, I., Ibrahim, Y., Elhardello, O. (2018) ‘Prevalence, types and determinants of anemia among pregnant women in Sudan: A systematic review and meta-analysis’, BMC Hematol, vol. 18, no. 31.
12. Adam, M. A., Adam, N. K., Mohamed, B. A. (2019) ‘Prevalence of sickle cell disease and sickle cell trait among children admitted to Al Fashir Teaching Hospital North Darfur State, Sudan’, BMC Research Notes, vol. 12, p. 659.
13. Adeyemi, A. B., Adediran, I. A., Kuti, O., Owolabi, A. T., Durosimi, M. A. (2009) ‘Outcome of pregnancy in a population of Nigerian women with sickle cell trait’, J Obstet Gynaecol, vol. 26, no. 2, pp. 133–137.
14. Naik RP, Haywood C Jr. Sickle cell trait diagnosis: clinical and social implications. Hematology Am Soc Hematol Educ Program. 2015;2015(1):160-7. doi: 10. 1182/ asheducation-2015.1.160. PMID: 26637716.
15. de Weerth C, Buitelaar JK. Physiological stress reactivity in human pregnancy--a review. Neurosci Biobehav Rev. 2005 Apr;29(2):295-312. doi: 10.1016/j.neubiorev.2004.10.005. PMID: 15811500.
16. Bjelica A, Cetkovic N, Trninic-Pjevic A, Mladenovic-Segedi L. The phenomenon of pregnancy - a psychological view. Ginekol Pol. 2018;89(2):102-106. doi: 10. 5603 / GP. a2018.0017. PMID: 29512815
17. O'Hara C, Singer DE, Niebuhr DW. The Risk of Pregnancy Related Hypertension Disorder Associated with Sickle Cell Trait in U.S. Service Women. Mil Med. 2020 Feb 12;185(1-2):e183-e190. doi: 10.1093/milmed/usz143. PMID: 31247087
18. Ugboma HAA, George IO. Sickle Cell Disease in Pregnancy: Maternal and Fetal Outcome in Port Harcourt, Nigeria. J Adv Med Medical Res. 2015; 7(1): 40-44. DOI: 10. 9734 /BJMMR /2015/11602.
19. Hamdi IM, Kamakshi S K, Ghani EA. Pregnancy outcome in women with sickle cell trait. Saudi Med J. 2002 Dec;23(12):1455-7. PMID: 12518190.
20. Manzar. S Maternal sickle cell trait and fetal hypoxia. Am J Perinatol. 2000;17(7):367-70. doi: 10.1055/s-2000-13444. PMID: 12141523 DOI: 10.1055/s-2000-13444.
21. Taylor MY, Wyatt-Ashmead J, Gray J, Bofill JA, Martin R, Morrison JC. Pregnancy loss after first-trimester viability in women with sickle cell trait: time for a reappraisal?. Am J Obstet Gynecol. 2006 Jun;194(6):1604-8. doi: 10.1016/j.ajog.2006.02.027. Epub 2006 Apr 25. PMID: 16635469.
22. Hoff C, Wertelecki W, Dutt J, Hernandez R, Reyes E, Sharp M. Sickle cell trait, maternal age and pregnancy outcome in primiparous women. Hum Biol. 1983 Dec;55(4):763-70. PMID: 6674100
23. Rathod, K. B., Jaiswal, K. N., Shrivastava, A. C., Shrikhande, A. V. (2007) ‘Study of the placenta in sickle cell disorders’, Indian J Pathol Microbiol. 2007 Oct;50(4):698-701. PMID: 18306531
24. Wilson, S., Ellsworth, P., Key, N. S. Pregnancy in sickle cell trait: What we do and don’t know’, Br J Haematol. 2020 Aug;190 (3):328-335. doi: 10.1111/bjh.16518. Epub 2020 Feb 17.
25. S M Tuck SM, Studd JW, White JM. Pregnancy in women with sickle cell trait. Br J Obstet Gynaecol. 1983 Feb;90(2):108-11. doi: 10.1111/j.1471-0528.1983.tb08892.x. PMID: 6824609 DOI: 10.1111/j.1471-0528.1983.tb08892.x
26. Wellenstein WL, Sullivan S, Darbinian J, Weintraub MLR, Greenberg M, Adverse Pregnancy Outcomes in Women with Sickle Cell Trait. AJP Rep. 2019 Oct;9(4):e346-e352. doi: 10.1055/s-0039-1695743. Epub 2019 Nov 11. PMID: 31723455 PMCID: PMC6847694 DOI: 10.1055/s-0039-1695743
27. Adeyemi AB, Adediran IA, Kuti O, Owolabi AT, Durosimi MA. Outcome of pregnancy in a population of Nigerian women with sickle cell trait. J Obstet Gynaecol. 2006 Feb;26(2):133-7. doi: 10.1080/01443610500443428. PMID: 16483970
28. Baill IC, Witter FR. Sickle trait and its association with birthweight and urinary tract infections in pregnancy. Int J Gynaecol Obstet. 1990 Sep;33(1):19-21. doi: 10.1016/0020-7292(90)90649-6.. PMID: 1974527 DOI: 10.1016/0020-7292(90)90649-6
29. Munsoor, M. M., Alabid, A. SCT among relatives of sickle cell patients in Western Sudan. Canad. J. Med, 2011; 2 (2): 20–25.
30. Piel, F. B., Patil, A. P., Howes, R. E., Nyangiri, O. A., Gething, P. W., Williams, T. N., Weatherall, D. J., Hay, S. I. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nat Commun. 2010 Nov 2;1:104. doi: 10 .1038 /ncomms1104: PMID: 21045822 PMCID: PMC3060623 DOI: 10.1038/ncomms1104.
31. Al Arrayed S, Al Hajeri A, Newborn Screening Services in Bahrain between 1985 and 2010. Adv Hematol. 2012;2012:903219. doi: 10.1155/2012/903219. Epub 2012 Apr 8. PMID: 22550494 PMCID: PMC3328916 DOI: 10.1155/2012/903219
32. Kadry S, Sleem C, Samad RA. Hemoglobin levels in pregnant women and its outcomes. Biom Biostat Int J. 2018;7(4):326-336. DOI: 10.15406/bbij.2018.07.00226
33. Solomon, Y., Sema, A., Menberu, T. Adherence and associated factors to iron and folic acid supplementation among pregnant women attending antenatal care in public hospitals of Dire Dawa, Eastern Ethiopia. Eur J Midwifery. 2021 Aug 25;5:35. doi: 10.18332/ejm/138595. eCollection 2021.
34. Tarekegn, M., Wubshet, M., Atenafu, A., Derso, T., Woretaw, A. Antenatal care and mothers' education improved iron-folic acid adherence at Denbiya district health centers, Northwest Ethiopia: using pills count method. Arch Public Health. 2019 Jun 25;77:30. doi: 10.1186/s13690-019-0356-y. eCollection 2019.
35. Gebremariam, A. D., Tiruneh, S. A., Abate, B. A., Engidaw, M. T., Asnakew, D. T. Adherence to iron with folic acid supplementation and its associated factors among pregnant women attending antenatal care follow up at Debre Tabor General Hospital, Ethiopia, 2017. PLoS One. 2019 Jan 7;14(1):e0210086. doi: 10.1371/journal.pone.0210086. eCollection 2019.
36. Peña-Rosas JP, De-Regil LM, Gomez Malave H, Flores-Urrutia MC, Dowswell T. Intermittent oral iron supplementation during pregnancy. Cochrane Database Syst Rev. 2015 Oct 19;2015(10):CD009997. doi: 10.1002/14651858.CD009997.pub2. PMID: 26482110
37. Ro Nneli 1, Sca Amadi, Wc Nwafia. Certain red blood cell indices of maternal and umbilical cord blood in owerri, Nigeria: a preliminary report. Ann Med Health Sci Res. 2011 Jan;1(1):1-8. PMID: 23209948 PMCID: PMC3507085
38. Dapper DV, Didia BC. Haemorheological parameters of umbilical cord blood of Nigerian newborns: correlations with maternal parameters. West Afr J Med. Jul-Sep 2006;25(3):226-30. doi: 10.4314/wajm.v25i3.28283. PMID: 17191424 DOI: 10.4314/wajm.v25i3.28283
39. Sanni OB, Chambers T, Li JH , Rowe S , Woodman AG , Ospina MB, Bourque SL. A systematic review and meta-analysis of the correlation between maternal and neonatal iron status and haematologic indices. EClinical Medicine. 2020 Oct 8;27:100555. doi: 10.1016/j.eclinm.2020.100555. eCollection 2020 Oct. PMID: 33205030 PMCID: PMC7648126 DOI: 10.1016/j.eclinm.2020.100555
40. Angelo A, Derbie G, Demtse A, Tsegaye A, Umbilical cord blood hematological parameters reference interval for newborns from Addis Ababa, Ethiopia. BMC Pediatr. 2021 Jun 11 ;21 (1):275. doi: 10.1186/s12887-021-02722-z. .. PMID: 34116664 PMCID: PMC8194248 DOI: 10.1186/s12887-021-02722-z.
41. Snook J, Bhala N, Beales ILP, Cannings D, Kightley C, Logan RPH, Pritchard DM, Sidhu R, Surgenor S,Thomas W, Verma AM, Goddard AF, British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut 2021;0:1–22. doi:10.1136/gutjnl-2021-325210.
42. Angelo A., Derbie G, Demtse A., Tsegaye A. Umbilical cord blood hematological parameters reference interval for newborns from Addis Ababa, Ethiopia. BMC Pediatr. 2021 Jun 11;21(1):275. doi: 10.1186/s12887-021-02722-z.
43. Baill, I. C., Witter, F. R. Sickle trait and its association with birthweight and urinary tract infections in pregnancy. Int J Gynaecol Obstet. 1990 Sep;33(1):19-21. doi: 10.1016/0020-7292(90)90649-6.
44. Barfield, W. D., Barradas, D. T., Manning, S. E., Kotelchuck, M., Shapiro-Mendoza, C. K. . Sickle cell disease and pregnancy outcomes: women of African descent. Am J Prev Med. 2010 Apr;38(4 Suppl):S542-9. doi: 10.1016/j.amepre.2009.12.020.
45. Bjelic A, Cetkovic N, Trninic-Pjevic A, Mladenovic-Segedi L. The phenomenon of pregnancy: a psychological view. Ginekol Pol. 2018;89(2):102-106. doi: 10 .5603 /GP .a2018.0017. PMID: 29512815 DOI: 10.5603/GP.a2018.0017.
46. Claster S, Vichinsky EP, Managing sickle cell disease. BMJ. 2003 Nov 15;327(7424):1151-5. doi: 10.1136/bmj.327.7424.1151. PMID: 14615343
47. Daak, A. A., Elsamani, E., Ali, E. H., Ghebremeskel, K., Fatma, A. M., Manar, E. A. Sickle cell disease in western Sudan: Genetic epidemiology and predictors of knowledge attitude and practice. Trop Med Int Health. 2016 May;21(5):642-53. doi: 10.1111/tmi.12689. Epub 2016 Mar 29.
48. Dapper D V, Didia B C. Haemorheological parameters of umbilical cord blood of Nigerian newborns: Correlations with maternal parameters. West Afr J Med. Jul-Sep 2006 ;25(3):226-30. doi: 10.4314/wajm.v25i3.28283.
49. De Weerth C, Buitelaar J. K. Physiological stress reactivity in human pregnancy – A review. Neurosci Biobehav Rev. 2005 Apr;29(2):295-312. doi: 10.1016/ j.neubiorev. 2004 .10.005.PMID: 15811500.
50. El-Hazmi MAF, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011 Nov;134(5):597-610. doi: 10.4103/0971-5916.90984.
51. Elgari, M., Waggiallah, H. A. Cord blood hematological profile of Sudanese neonates at birth in Khartoum State. National Journal of Integrated Research in Medicine, 2014; 5(4):22-25. eISSN: 0975-9840 pISSN: 2230 - 9969
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.